179 related articles for article (PubMed ID: 37168359)
1. Bromelain and acetylcysteine (BromAc
Wen HK; Valle SJ; Morris DL
Am J Cancer Res; 2023; 13(4):1522-1532. PubMed ID: 37168359
[TBL] [Abstract][Full Text] [Related]
2. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.
Valle SJ; Akhter J; Mekkawy AH; Lodh S; Pillai K; Badar S; Glenn D; Power M; Liauw W; Morris DL
Eur J Surg Oncol; 2021 Jan; 47(1):115-122. PubMed ID: 31679953
[TBL] [Abstract][Full Text] [Related]
3. Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei.
Lam AR; Bazzi K; Valle SJ; Morris DL
Case Rep Oncol; 2021; 14(1):628-633. PubMed ID: 33976645
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Treatment of Unresectable Pseudomyxoma Peritonei with Multiple Treatments of Intratumoural Bromelain and Acetylcysteine (BromAc
Yang J; Glenn D; Lodh S; Valle S; Morris DL
Case Rep Oncol; 2023; 16(1):1551-1556. PubMed ID: 38074518
[TBL] [Abstract][Full Text] [Related]
5. Effective Use of Bromelain and Acetylcysteine (BromAc
Skalkos E; Chen KL; Wijayawardana R; Morris DL
Anticancer Res; 2023 Oct; 43(10):4735-4738. PubMed ID: 37772592
[TBL] [Abstract][Full Text] [Related]
6. Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.
Coelho Dos Reis JGA; Ferreira GM; Lourenço AA; Ribeiro ÁL; da Mata CPDSM; de Melo Oliveira P; Marques DPA; Ferreira LL; Clarindo FA; da Silva MF; Filho HPP; Oliveira NRR; Sodré MMD; Gadelha SR; Albuquerque GR; Maciel BM; Mariano APM; Silva MM; Fontana R; Marin LJ; Carlos RSA; Lopes ATS; Ferreira FB; Dos Santos UR; Santana ÍTS; Fehlberg HF; Rezende RP; Dias JCT; Gross E; Goulart GAC; Santiago MG; de Lemos APML; da Conceição AO; Romano CC; de Carvalho LD; Martins Filho OA; Quadros CA; Morris DL; Valle SJ
Biomed Pharmacother; 2022 Apr; 148():112753. PubMed ID: 35272139
[TBL] [Abstract][Full Text] [Related]
7. A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.
Dong L; Ke K; Badar S; Mekkawy AH; Akhter J; Pillai K; Carter CJ; Morris DL
Am J Transl Res; 2022; 14(5):2894-2909. PubMed ID: 35702130
[TBL] [Abstract][Full Text] [Related]
8. Effect of Nebulized BromAc on Rheology of Artificial Sputum: Relevance to Muco-Obstructive Respiratory Diseases.
Pillai K; Mekkawy AH; Akhter J; Morris DL
Adv Respir Med; 2023 Apr; 91(2):146-163. PubMed ID: 37102780
[TBL] [Abstract][Full Text] [Related]
9. Bromelain and acetylcysteine (BromAc
Mekkawy AH; Pillai K; Suh H; Badar S; Akhter J; Képénékian V; Ke K; Valle SJ; Morris DL
Am J Transl Res; 2021; 13(12):13524-13539. PubMed ID: 35035694
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal BromAc
Mekkawy AH; Breakeit M; Pillai K; Badar S; Akhter J; Valle SJ; Morris DL
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444430
[TBL] [Abstract][Full Text] [Related]
11. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
[TBL] [Abstract][Full Text] [Related]
12. The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.
Akhter J; Quéromès G; Pillai K; Kepenekian V; Badar S; Mekkawy AH; Frobert E; Valle SJ; Morris DL
Viruses; 2021 Mar; 13(3):. PubMed ID: 33800932
[TBL] [Abstract][Full Text] [Related]
13. Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
J Surg Res; 2012 May; 174(2):e69-73. PubMed ID: 22261589
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of bromelain and acetylcysteine in pseudomyxoma peritonei (PMP) caused by low-grade appendiceal mucinous neoplasm (LAMN): a case report.
Geisel D; Langen U; Rüdiger T
J Med Case Rep; 2023 Jun; 17(1):297. PubMed ID: 37381056
[TBL] [Abstract][Full Text] [Related]
15. The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study.
Ke K; Pillai K; Mekkawy AH; Akhter J; Badar S; Valle SJ; Morris DL
Discov Oncol; 2021 Aug; 12(1):25. PubMed ID: 35201475
[TBL] [Abstract][Full Text] [Related]
16. Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition
Mekkawy AH; Pillai K; Badar S; Akhter J; Ke K; Valle SJ; Morris DL
Am J Cancer Res; 2021; 11(5):2252-2263. PubMed ID: 34094682
[TBL] [Abstract][Full Text] [Related]
17. Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine.
Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Morris DL
Oncotarget; 2015 Oct; 6(32):33329-44. PubMed ID: 26436698
[TBL] [Abstract][Full Text] [Related]
18. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
[TBL] [Abstract][Full Text] [Related]
19. Mucinous epithelial cysts of the spleen associated with pseudomyxoma peritonei.
Du Plessis DG; Louw JA; Wranz PA
Histopathology; 1999 Dec; 35(6):551-7. PubMed ID: 10583579
[TBL] [Abstract][Full Text] [Related]
20. Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer.
Miyashita T; Murata K; Hoshino E; Nishiya H; Ono Y; Akaoka I; Kunii O
Dig Dis Sci; 1999 Nov; 44(11):2231-4. PubMed ID: 10573367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
